Structure-activity relationship of alkyl camptothecin esters

Annals of the New York Academy of Sciences

Volumn 922, Issue , 2000, Pages 122-135

  Zhisong, C A O ^a,b   Fantazis, Panayotis ^a   Mendoza, John ^a   Early, Janet ^a   Kozielski, Anthony ^a   Harris, Nick ^a   Vardeman, Dana ^a   Liehr, Joachim ^a   Stehlin, John S ^a   Giovanella, Beppino ^a  

^a St Joseph's Medical Center Houston   (United States)

^b Stehlin Found for Cancer Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAMPTOTHECIN DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; BREAST CANCER; CELL FREE SYSTEM; COLON CANCER; CONFERENCE PAPER; CONTROLLED STUDY; DRUG ACTIVITY; DRUG STRUCTURE; ENZYME STABILITY; FEMALE; FLOW CYTOMETRY; LIVER HOMOGENATE; MOUSE; NONHUMAN; STRUCTURE ANALYSIS;

ANIMALIA; MUS MUSCULUS;

EID: 0034515727     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2000.tb07031.x     Document Type: Conference Paper

References (38)

1. Plant antitumor agents. I. The isolation and structure of camptothecin, a novel alkaloidal leukemia and tumor inhibitor from Camptotheca acuminata
2. Biochemical basis for the interactions of type I and type II topoisomerases with DNA
3. Synthesis of some DE and CDE ring analogues of camptothecin
4. Synthesis and biological evaluation of DE-AB-camptothecin
5. Analogs of camptothecin
6. Experiments on the synthesis of dl-camptothecin. 4. Synthesis and antileukemic activity of dl-camptothecin analogs
7. Plant antitumor agents. 18. Synthesis and biological activity of camptothecin analogs
8. Plant antitumor agents. 23. Synthesis and antileukemic activity of camptothecin analogs
9. Plant antitumor agents. 25. Total synthesis and antileukemic activity of ring A substituted camptothecin analogs. Structure-activity correlations
10. Plant antitumor agent. 29. Synthesis and biological activity of ring D and ring E modified analogues of camptothecin
11. Synthesis of water soluble (aminoalkyl)camptothecin analogues: Inhibition of topoisomerase I and antitumor activity
12. Antitumor agents. V. Synthesis and antileukemic activity of E-ring modified (RS)-camptothecin
13. Synthesis and antitumor activity of 20 (S)-camptothecin derivatives. A-ring-substituted 7-ethylcamptothecins and their E-ring-modified water soluble derivatives
14. The synthesis and evaluation of flexible analogs of the topoisomerase I inhibitor, camptothecin
15. Antitumor agents. 160. The synthesis of 5-substituted camptothecins as potential inhibitor of DNA topoisomerase I
16. Synthesis and antitumor activity of novel water soluble derivatives of camptothecin as specific inhibitors of topoisomerase I
17. Synthesis of 18-noranhydrocamptothecin analogs which retain topoisomerase I inhibitory function
18. Catalytic enantioselective synthesis of 20 (S)-camptothecin: A practical application of the sharpless asymmetric dihydroxylation reaction
19. Asymmetric synthesis of camptothecin alkaloids: A nine step synthesis of (S)-camptothecin
20. Regioselective synthesis of camptothecin
21. Comparative molecular field analysis and molecular modeling studies of 20-(S)-camptothecin analogs as inhibitors of DNA topoisomerase I and anticancer/antitumor agents
22. Sensitivity of camptothecin-resistant human leukemia cells and tumors to anticancer drugs with diverse mechanisms of action
23. Preclinical studies of water-insoluble camptothecin congeners: Cytotoxicity, development of resistance, and combination treatments
24. Chemistry of the camptothecins in the bloodstream: Drug stabilization and optimization of activity
25. Complete growth inhibition of human cancer xenografts in nude mice by treatment with 20 (S) camptothecin
26. Phase I clinical and pharmacological studies of 20-(S)-camptothecin and 20-(S)-9-Cao Z nitrocamptothecin as anticancer agents
27. An alternative preparation of camptothecin 20(S)-acetate
28. Antineoplastic structure-activity relationships of camptothecin and related analogs. Natural products and drug development
29. Alkyl esters of camptothecin and 9-nitrocamptothecin: Synthesis, in vitro pharmacokinetics, toxicity, and antitumor activity
30. The water-insoluble camptothecin analogues: Promising drugs for the effective treatment of hematological malignancies
31. Heterotransplantation of human malignant tumors in "nude" thymusless mice. I. Breeding and maintenance of "nude" mice
32. Cytotoxic efficacy of 9-nitrocamptothecin in the treatment of human malignant melanoma cells in vitro
33. Selective lethal effect on thymidine on human and mouse tumor cells
34. L-Homoserine hydroxamic acid as an antitumor agent
35. Identification of a mutant human topoisomerase I with intact catalytic activity and resistance to 9-nitrocamptothecin
36. Partial characterization of human leukemia U-937 cell sublines to 9-nitrocamptothecin
37. Camptothecin: Discovery to clinic